Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance-Reference-Cited by-同舟云学术

Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance

Published:2017-04-26 Issue:28 Volume:8 Page:45848-45861
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Xu Yuan-Yuan¹,Guo Ming²,Yang Liu-Qing¹,Zhou Fan¹,Yu Cao¹,Wang Aixiu¹,Pang Tao-Hong¹,Wu Hong-Yan³,Zou Xiao-Ping¹,Zhang Wei-Jie⁴⁵,Wang Lei¹,Xu Gui-Fang¹,Huang Qin³⁶

Affiliation:

1. Department of Gastroenterology, Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, Jiangsu, China

2. Department of Gastroenterology, People's Hospital of Anji, Huzhou, China

3. Department of Pathology, Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, Jiangsu, China

4. Department of Gastrointestinal Surgery, Nanjing Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, Jiangsu, China

5. Department of General Surgery, Nanjing Drum Tower Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu, China

6. Department of Pathology, VA Boston Healthcare System and Harvard Medical School, Boston, MA, United States

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blocking EGR1/TGF-β1 and CD44s/STAT3 Crosstalk Inhibits Peritoneal Metastasis of Gastric Cancer;International Journal of Biological Sciences;2024

2. CD44v6 acts as a directional responding factor in the process of transcoelomic metastasis from gastric carcinoma to Krukenberg tumor;Expert Review of Molecular Diagnostics;2023-07-03

3. Reduced DEFA5 Expression and STAT3 Activation Underlie the Submucosal Invasion of Early Gastric Cancers;Digestion;2023

4. CD44v6 High Membranous Expression Is a Predictive Marker of Therapy Response in Gastric Cancer Patients;Biomedicines;2021-09-18

5. CD44v6-targeted CAR T-cells specifically eliminate CD44 isoform 6 expressing head/neck squamous cell carcinoma cells;Oral Oncology;2021-05